Factors Associated With Excess Myocardial Infarction Risk in HIV-Infected Adults: A Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Objectives: To estimate the pooled relative risk (RR) of incident acute myocardial infarction (AMI) among HIV-infected adults compared with HIV-uninfected controls and explore the contribution of traditional and HIV-related risk factors.
Background: Understanding AMI risk and associated risk factors in HIV-infected populations has the potential to inform clinical management and prevention strategies.
Methods: We systematically identified cohort studies of HIV-infected or HIV-infected and matched uninfected adults reporting AMI incidence rates published up to January 1, 2017. Random-effects meta-analysis models were used to estimate the aggregate RR of AMI by HIV status. Subgroup analysis and meta-regression were used to explore factors affecting risk.
Results: Sixteen studies (N = 1,619,690, median age 38.5 years, 78.9% male, mean follow-up of 6.5 years) were included. In pooled analyses of HIV-infected and matched uninfected cohorts (n = 5), HIV-infected individuals had higher AMI incidence rates (absolute risk difference = 2.2 cases per 1000 persons per year) and twice the risk of AMI [RR = 1.96 (1.5-2.6)] compared with matched HIV-uninfected controls. In a multivariate meta-regression, each additional percentage point in the proportion of male participants [odds ratio (OR) = 1.20 (1.14-1.27)] and each additional percentage point in the prevalence of hypertension [OR = 1.19 (1.12-1.27)], dyslipidemia [OR = 1.09 (1.07-1.11)], and smoking [OR = 1.09 (1.05-1.13)] were independently associated with increased AMI risk in HIV-infected adults.
Conclusions And Relevance: Chronic HIV infection is associated with a 2-fold higher AMI risk. Traditional risk factors such as hypertension, dyslipidemia, and smoking are significant contributors to AMI risk among HIV-infected adults and should be aggressively targeted in routine HIV care.
Soldea S, Iovanescu M, Berceanu M, Mirea O, Raicea V, Bezna M Int J Mol Sci. 2025; 26(5).
PMID: 40076466 PMC: 11899583. DOI: 10.3390/ijms26051837.
Understanding barriers and facilitators to integrated HIV and hypertension care in South Africa.
Johnson L, Khan S, Ali M, Galaviz K, Waseem F, Ordonez C Implement Sci Commun. 2024; 5(1):87.
PMID: 39090730 PMC: 11295645. DOI: 10.1186/s43058-024-00625-5.
Manne-Goehler J, Fabian J, Sokhela S, Akpomiemie G, Rahim N, Lalla-Edward S J Int AIDS Soc. 2024; 27(7):e26268.
PMID: 38978403 PMC: 11231445. DOI: 10.1002/jia2.26268.
A model-based approach to estimating the prevalence of disease combinations in South Africa.
Johnson L, Kassanjee R, Folb N, Bennett S, Boulle A, Levitt N BMJ Glob Health. 2024; 9(2).
PMID: 38388163 PMC: 10884267. DOI: 10.1136/bmjgh-2023-013376.
Masunda K, Khan Z Cureus. 2023; 15(10):e46476.
PMID: 37927754 PMC: 10624240. DOI: 10.7759/cureus.46476.